CLASS II ONGOING Drug recall · Reported 18 Jun 2025 · FDA Enforcement Report

Chlorthalidone Tablets, USP, 25 mg Unit Dose cards recalled by AvKARE

AvKARE is recalling Chlorthalidone Tablets, USP, 25 mg Unit Dose cards per, distributed nationwide in the US. The recall was initiated on 9 May 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 47947, Exp 05/31/2026
NDC50268-167
Quantity recalled962 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0461-2025
FDA event ID
96866
Recalling firm
AvKARE, Pulaski, TN
Manufacturer
AvPAK
Classification
Class II
Status
Ongoing
Recall initiated
9 May 2025
FDA classified
9 Jun 2025
Reported
18 Jun 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

9 May 2025Recall initiated by company
9 Jun 2025Classified by FDA+31 days
18 Jun 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Dissolution Specifications

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-167-15

Where it was distributed

Nationwide USA

Nationwide

Questions about this recall

Why was it recalled?

Failed Dissolution Specifications

Which lots are affected?

Lot # 47947, Exp 05/31/2026

Where was it sold?

Nationwide USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from AvKARE

All 62
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAmantadine HCl, Capsules, UPS, 100 mg dose recalled by AvKAREAmantadine HclAvKAREPotency & AssayNationwide
DrugCLASS IIRosuvastatin Tablets, USP, 10 mg recalled by AvKARERosuvastatinAvKAREPotency & AssayNationwide
DrugCLASS IINorgestimate and Ethinyl Estradiol Tablets recalled by AvKARENorgestimate And Ethinyl EstradiolAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 100 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 50 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide

Other Chlorthalidone recalls

All 7